Antonio Costanzo

Prof. Antonio Costanzo


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 1999 in Nature
Verified
Journal Article
Closed access
PDF file
JGJianGen Gong
JianGen Gong
ACAntonio Costanzo
Antonio Costanzo
HYHong-Qiong Yang
Hong-Qiong Yang
GMGerry Melino
Gerry Melino
WKWilliam G. Kaelin
William G. Kaelin
JWJean Y. J. Wang
Jean Y. J. Wang

3 December 2014 in Nature Communications
Verified
Journal Article
Closed access
PDF file
Roberto LandeRoberto Lande
Roberto Lande
EBElisabetta Botti
Elisabetta Botti
CJCamilla Jandus
Camilla Jandus
DDDanijel Dojcinovic
Danijel Dojcinovic
GFGiorgia Fanelli
Giorgia Fanelli
Loredana FrascaLoredana Frasca
Loredana Frasca

10 January 1997 in Science
Verified
Journal Article
Closed access
PDF file
GNGioacchino Natoli
Gioacchino Natoli
ACAntonio Costanzo
Antonio Costanzo
AIAngelo Ianni
Angelo Ianni
DTDennis J. Templeton
Dennis J. Templeton
JWJames R. Woodgett
James R. Woodgett
MLMassimo Levrero
Massimo Levrero
Interaction of the p55 tumor necrosis factor receptor 1 (TNF-R1)-associated signal transducer TRADD with FADD signals apoptosis, whereas the TNF receptor-associated factor 2 protein (TRAF2) is required for activation of the nuclear transcription factor nuclear factor kappa B. TNF-induced activation of the stress-activated protein kinase (SAPK) was shown to occur through a noncytotoxic TRAF2-dependent pathway. TRAF2 was both sufficient and necessary for activation of SAPK by TNF-R1; conversely, expression of a dominant-negative FADD mutant, which blocks apoptosis, did not interfere with SAPK activation. Therefore, SAPK activation occurs through a pathway that is not required for TNF-R1-induced apoptosis.

2 November 1998 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
VLVincenzo De Laurenzi
Vincenzo De Laurenzi
ACAntonio Costanzo
Antonio Costanzo
DBDaniela Barcaroli
Daniela Barcaroli
Alessandro TerrinoniAlessandro Terrinoni
Alessandro Terrinoni
MFMirella Falco
Mirella Falco
GMGerry Melino
Gerry Melino
P73 has been recently identified as a new structural and functional homologue of the transcription factor p53. It is expressed in either a full-length form, α, or a shorter β mRNA variant, with exon 13 spliced out. Here we report the identification and functional characterization of two new p73 splicing variants, γ (splicing out exon 11) and δ (splicing out exons 11, 12, and 13). Both γ and δ p73 variants are expressed in human peripheral blood lymphocytes, primary keratinocytes, and different tumor cell lines, including neuroblastoma, glioblastoma, melanoma, hepatoma, and leukemia. The expression pattern of the four p73 splicing variants differs in both primary cells of different lineage and established cell lines even within the same type of tumor. A two-hybrid assay was used to characterize the homodimeric and heterodimeric interactions between the p73 variants, and showed that neither p73γ nor p73δ interact with p53, whereas p73γ showed strong interactions with all p73 isoforms, and p73δ binds efficiently p73α and p73γ but only weakly p73β. At the functional level, p73γ is significantly less efficient in activating transcription of the p21Waf1/Cip1 promoter than p53 or p73β, whereas the effect of p73δ is intermediate and comparable to that of p73α. The ability of the different p73 variants to affect cell growth in p53 null osteosarcoma SAOS-2 cells correlates with their transcriptional activity on the p21Waf1/Cip1 promoter: p73β is the most efficient in inhibiting colony formation, whereas p73γ is almost ineffective. Our results suggest that p73 isoforms may be differentially regulated, with four different isoforms capable of interacting among themselves and with p53. The relative expression level of each splice variant may modulate p73 transcriptional and growth suppression activities by affecting heterodimer formation.

1 January 2002 in Molecular Cell
Verified
Journal Article
Closed access
ACAntonio Costanzo
Antonio Costanzo
PMPaola Merlo
Paola Merlo
NPNatalia Pediconi
Natalia Pediconi
MFMarcella Fulco
Marcella Fulco
VSVittorio Sartorelli
Vittorio Sartorelli
MLMassimo Levrero
Massimo Levrero

19 May 2003 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
NPNatalia Pediconi
Natalia Pediconi
AIAlessandra Ianari
Alessandra Ianari
ACAntonio Costanzo
Antonio Costanzo
LBLaura Belloni
Laura Belloni
RGRita Gallo
Rita Gallo
MLMassimo Levrero
Massimo Levrero